- Investing Ideas
- U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
2 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Diaceutics
Market Cap: UK£118.4m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
New
DXRX
UK£1.44
7D
1.1%
1Y
4.4%
AstraZeneca
Market Cap: UK£187.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
New
AZN
UK£124.76
7D
5.7%
1Y
5.1%
hVIVO
Market Cap: UK£44.9m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.065
7D
-1.5%
1Y
-35.0%